Klinische Arzneimittelstudien: mehr Transparenz
Crossref DOI link: https://doi.org/10.1007/s12312-016-0134-5
Published Online: 2016-10-05
Published Print: 2016-10
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Hartmann, Markus
License valid from 2016-10-01